These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4957389)

  • 1. Influence of the substantia nigra on the concentration of 5-hydroxytryptamine and dopamine of the striatum.
    Sourkes TL; Poirier L
    Nature; 1965 Jul; 207(993):202-3. PubMed ID: 4957389
    [No Abstract]   [Full Text] [Related]  

  • 2. INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM.
    POIRIER LJ; SOURKES TL
    Brain; 1965 Mar; 88():181-92. PubMed ID: 14280273
    [No Abstract]   [Full Text] [Related]  

  • 3. [INFLUENCE OF LOCUS NIGER ON THE CONCENTRATION OF CATECHOLAMINES IN THE STRIATUM].
    POIRIER LJ; SOURKES TL
    J Physiol (Paris); 1964; 56():426-7. PubMed ID: 14219844
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of amines in the striatum in monkeys with nigral lesions. The disposition, biosynthesis and metabolites of [3H]dopamine and [14C]serotonin in the striatum.
    Goldstein M; Anagnoste B; Battista AF; Owen WS; Nakatani S
    J Neurochem; 1969 Apr; 16(4):645-53. PubMed ID: 4976670
    [No Abstract]   [Full Text] [Related]  

  • 5. Lesion of substantia nigra: biochemical and behavioral effects in rats.
    Gumulka W; Ramirez del Angel A; Samanin R; Valzelli L
    Eur J Pharmacol; 1970 Apr; 10(1):79-82. PubMed ID: 5441100
    [No Abstract]   [Full Text] [Related]  

  • 6. On the intracerebral origin of homovanillic acid of the cerebrospinal fluid of experimental animals.
    Papeschi R; Sourkes TL; Poirier LJ; Boucher R
    Brain Res; 1971 May; 28(3):527-33. PubMed ID: 5000053
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease of dopamine and 5-hydroxytryptamine after intracerebral application of 5,6-dihydroxytryptamine.
    Saner A; Pieri L; Moran J; Da Prada M; Pletscher A
    Brain Res; 1974 Aug; 76(1):109-17. PubMed ID: 4844098
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin innervation of basal ganglia in monkeys and humans.
    Parent M; Wallman MJ; Gagnon D; Parent A
    J Chem Neuroanat; 2011 Jul; 41(4):256-65. PubMed ID: 21664455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LH syndrome and brain catecholamine levels after lesions of the nigrostriatal bundle.
    Oltmans GA; Harvey JA
    Physiol Behav; 1972 Jan; 8(1):69-78. PubMed ID: 4665334
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra.
    Faull RL; Laverty R
    Exp Neurol; 1969 Mar; 23(3):332-40. PubMed ID: 5767257
    [No Abstract]   [Full Text] [Related]  

  • 11. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod.
    Bergquist F; Shahabi HN; Nissbrandt H
    Brain Res; 2003 May; 973(1):81-91. PubMed ID: 12729956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topographical distributions of 32K and 48K cAMP-regulated phosphoproteins: relationships to dopamine and serotonin innervations in striatum, substantia nigra and cerebral cortex.
    Lemos JR; Barberis C; Tassin JP; Bockaert J
    Brain Res; 1984 Dec; 323(1):47-54. PubMed ID: 6098335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural chemoanatomy of the basal ganglia: an overview.
    Pasik P; Pasik T; Holstein GR
    Adv Neurol; 1987; 45():59-66. PubMed ID: 2881451
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurochemical bases of tremor and other disorders of movement.
    Sourkes TL; Poirier LJ
    Can Med Assoc J; 1966 Jan; 94(2):53-60. PubMed ID: 4380339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.
    Zhou FC; Bledsoe S; Murphy J
    Brain Res; 1991 Aug; 556(1):108-16. PubMed ID: 1718555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in accumulation of tritium-labeled norepinephrine, 5-hydroxytryptamine and gamma-aminobutyric acid in brain slices of spider and rhesus monkey.
    Snyder SH; Hendley ED; Gfeller E
    Brain Res; 1969 Dec; 16(2):469-77. PubMed ID: 4982784
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental midbrain lesions: neurochemical comparison between the animal model and Parkinson's disease.
    Hockman CH; Lloyd KG; Farley IJ; Hornykiewicz O
    Brain Res; 1971 Dec; 35(2):613-8. PubMed ID: 5135560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.